Pain After Proximal Digital Amputation Prevention (PAPDAP)

August 28, 2023 updated by: Joshua Adkinson, Indiana University
Finger amputations are common and may be complicated by debilitating nerve pain. This study seeks to determine if nerve pain after digital amputation can be more effectively prevented with either of two new surgical techniques-targeted muscle reinnervation (TMR) or regenerative peripheral nerve interfaces (RPNI)-compared to standard treatment by traction neurectomy (TN).

Study Overview

Status

Terminated

Intervention / Treatment

Detailed Description

Patients who require proximal amputations will have the opportunity to enroll in the study, will be randomized intraoperatively to receiving one of the aforementioned treatments, and will be followed at 3 and 6 month for outcome measures.

Study Type

Interventional

Enrollment (Actual)

39

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Indianapolis, Indiana, United States, 46202
        • Eskenazi Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients requiring single finger amputations at the level of the proximal interphalangeal joint or proximal (i.e., closer to the body than this joint).
  • Patients have the capacity to complete the informed consent process

Exclusion Criteria:

  • Patients less than 18 years of age, prisoner, or other vulnerable population
  • Patients with significant concomitant ipsilateral extremity injuries that would confound study
  • Patients requiring emergent, staged (guillotine-type) amputations of any kind

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Traction Neurectomy
Traction neurectomy - of digital sensory nerves at the time of amputation.
The type of procedure performed on the digital nerve at the time of amputation
Experimental: Targeted Muscle Reinnervation
Targeted Muscle Reinnervation - of digital sensory nerves at the time of amputation
The type of procedure performed on the digital nerve at the time of amputation
Experimental: Regenerative Peripheral Nerve Interface
Regenerative Peripheral Nerve Interface - of digital sensory nerves at the time of amputation
The type of procedure performed on the digital nerve at the time of amputation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
bMHQ
Time Frame: 3 months postop minus preop; 6 months postop minus preop
Breif Michigan Hand Questionnaire Score difference
3 months postop minus preop; 6 months postop minus preop

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NPS
Time Frame: 3 months postop minus preop; 6 months postop minus preop
Numerical Pain Score difference
3 months postop minus preop; 6 months postop minus preop
Grip strength
Time Frame: 3 months postop minus preop; 6 months postop minus preop
Grip strength score difference
3 months postop minus preop; 6 months postop minus preop

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tinel's sign
Time Frame: Tinel's sign at 3 months; Tinel's sign at 6 months
Tinel's sign at amputation site
Tinel's sign at 3 months; Tinel's sign at 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joshua Adkinson, MD, Indiana University
  • Principal Investigator: Scott N Loewenstein, MD, Indiana University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2020

Primary Completion (Actual)

February 1, 2023

Study Completion (Actual)

February 1, 2023

Study Registration Dates

First Submitted

May 4, 2020

First Submitted That Met QC Criteria

May 4, 2020

First Posted (Actual)

May 7, 2020

Study Record Updates

Last Update Posted (Actual)

August 30, 2023

Last Update Submitted That Met QC Criteria

August 28, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Digital nerve procedure

Subscribe